LYTIR

Company · BNGO

Bionano Genomics, Inc.

Nasdaq's symbol directory lists BNGO on Nasdaq as “Bionano Genomics, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 2 occasions ($10K); 3 filings by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $10K in total; Insider sales: $0 in total.Aug: Insider purchases $5KSep: Insider purchases $5KDecJanFebMarAprMayJunJulAugSepOctNov$5K
Insider purchases above the line: $10KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Luderer Albert, Interim Chief Executive bought on 2 days latest Sep 4, 2026 bought $10K
Every trade (2)
  1. BUYLuderer Albert, Interim Chief Executive bought Sep 4, 2026 4,000 shares filing $5K
  2. BUYLuderer Albert, Interim Chief Executive bought Aug 21, 2026 4,000 shares filing $5K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. CVI Investments, Inc. filed Nov 16, 2026 Schedule 13G/A passive filing 9.9%
  2. Orin Hirschman filed Oct 19, 2026 Schedule 13G passive filing 9.9%
  3. CVI Investments, Inc. filed Aug 14, 2026 Schedule 13G/A passive filing 9.9%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 10, 2026
  2. Regulation FD disclosure filing Sep 14, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.